News

Filter

Current filters:

None

10 to 19 of 97916 results

Novogen’s TRXE-009 kills brain cancer stem cells

Novogen’s TRXE-009 kills brain cancer stem cells

05-03-2015

Shares of Australian biotech company Novogen rose dramatically as it announced that one of its lead candidate…

AustraliaBiotechnologyNovogenOncologyResearch

Biopharma sector subject to highest economic uncertainty of major European industries: report

Biopharma sector subject to highest economic uncertainty of major European industries: report

05-03-2015

The European biopharma sector faces the highest level of risk and economic uncertainty of six key European…

EuropeJanssenJohnson & JohnsonMarkets & MarketingPharmaceutical

Baxter acquires biopharmaceutical firm SuppreMol

Baxter acquires biopharmaceutical firm SuppreMol

04-03-2015

US health care product company Baxter International has acquired SuppreMol GmbH for 200 million euros…

Baxter InternationalBiotechnologyImmunologicalsSuppreMol

InMed appoints Abo Mohammed as chief medical officer

InMed appoints Abo Mohammed as chief medical officer

04-03-2015

Canadian cannabinoid therapy specialist InMed Pharmaceuticals has appointed Abo Mohammed as chief medical…

BoardroomCanadaInMedInMed PharmaceuticalsPharmaceutical

FDA accepts Bayer's BLA for hemophilia A agent Kovaltry

FDA accepts Bayer's BLA for hemophilia A agent Kovaltry

04-03-2015

The US Food and Drug Administration has accepted German pharma major Bayer’s Biologics License Application…

BAY 81-8973BayerBiotechnologyHematologyKovaltryRegulationUSA

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

04-03-2015

Clinical-stage biopharma company arGEN-X has exercised its option to exclusively license preclinical…

arGEN-XBelgiumBiotechnologyLicensingOncology

Ipsen appoints Dominique Laymand as senior vice president, chief ethics and compliance officer

Ipsen appoints Dominique Laymand as senior vice president, chief ethics and compliance officer

04-03-2015

French drug maker Ipsen has appointed Dominique Laymand as senior vice president, chief ethics and compliance…

BoardroomDominique LaymandFranceIpsenIpsen Group

10 to 19 of 97916 results

Back to top